These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 33930895)
1. Microparticles: An Alternative Explanation to the Behavior of Vascular Antiphospholipid Syndrome. Álvarez D; Rúa C; Cadavid J ÁP Semin Thromb Hemost; 2021 Oct; 47(7):787-799. PubMed ID: 33930895 [TBL] [Abstract][Full Text] [Related]
2. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome. Álvarez D; Morales-Prieto DM; Cadavid ÁP Autoimmun Rev; 2023 Apr; 22(4):103274. PubMed ID: 36649876 [TBL] [Abstract][Full Text] [Related]
3. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081 [TBL] [Abstract][Full Text] [Related]
4. Endothelial and platelet microparticles in patients with antiphospholipid antibodies. Breen KA; Sanchez K; Kirkman N; Seed PT; Parmar K; Moore GW; Hunt BJ Thromb Res; 2015 Feb; 135(2):368-74. PubMed ID: 25496997 [TBL] [Abstract][Full Text] [Related]
5. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? Pericleous C; Giles I; Rahman A Lupus; 2009 Jul; 18(8):671-5. PubMed ID: 19502261 [TBL] [Abstract][Full Text] [Related]
6. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications. Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063 [TBL] [Abstract][Full Text] [Related]
7. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome. Du VX; Kelchtermans H; de Groot PG; de Laat B Thromb Res; 2013 Sep; 132(3):319-26. PubMed ID: 23958468 [TBL] [Abstract][Full Text] [Related]
8. Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles? Campello E; Radu CM; Spiezia L; Simioni P Clin Chem Lab Med; 2017 Jun; 55(7):934-943. PubMed ID: 27816948 [TBL] [Abstract][Full Text] [Related]
9. Higher levels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipid antibodies. Martínez-Zamora MA; Tàssies D; Creus M; Reverter JC; Puerto B; Monteagudo J; Carmona F; Balasch J Hum Reprod; 2016 Jan; 31(1):46-52. PubMed ID: 26534898 [TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in endothelial cells induced by the serum of women with different clinical manifestations of the antiphospholipid syndrome. Velásquez M; Granada MA; Galvis JC; Álvarez ÁM; Cadavid Á Biomedica; 2019 Dec; 39(4):673-688. PubMed ID: 31860179 [TBL] [Abstract][Full Text] [Related]
11. Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome. Velásquez M; Peláez LF; Rojas M; Narváez-Sánchez R; Velásquez JA; Escudero C; San Martín S; Cadavid ÁP Front Physiol; 2021; 12():764702. PubMed ID: 34925061 [TBL] [Abstract][Full Text] [Related]
12. A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies. Niccolai E; Squatrito D; Emmi G; Silvestri E; Emmi L; Ciucciarelli L; Ricci F; Manganaro D; Amedei A; Prisco D Thromb Res; 2015 Dec; 136(6):1252-8. PubMed ID: 26476741 [TBL] [Abstract][Full Text] [Related]
13. Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. Graham A; Ford I; Morrison R; Barker RN; Greaves M; Erwig LP J Immunol; 2009 Feb; 182(3):1756-62. PubMed ID: 19155525 [TBL] [Abstract][Full Text] [Related]
14. Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome. Pericleous C; Clarke LA; Brogan PA; Latchman DS; Isenberg DA; Ioannou Y; Giles IP; Rahman A Thromb Haemost; 2013 Jan; 109(1):72-8. PubMed ID: 23152159 [TBL] [Abstract][Full Text] [Related]
15. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Boles J; Mackman N Lupus; 2010 Apr; 19(4):370-8. PubMed ID: 20353972 [TBL] [Abstract][Full Text] [Related]
16. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway. Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892 [TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4. Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610 [TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges. Štok U; Čučnik S; Sodin-Šemrl S; Žigon P Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925261 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome. Oku K; Amengual O; Atsumi T Eur J Clin Invest; 2012 Oct; 42(10):1126-35. PubMed ID: 22784367 [TBL] [Abstract][Full Text] [Related]